Ocugen (OCGN) Cash from Financing Activities (2014 - 2026)
Ocugen's Cash from Financing Activities was $80.37 million in Q2 2026, compared with $61,000 a year earlier and up 129.7% from the prior quarter.
Ocugen (OCGN) Cash from Financing Activities (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ocugen's Cash from Financing Activities was $133.86 million through Jun 30, 2026, up 109.9% year-over-year; for FY2025, it came in at $17.33 million, down 73.3% from FY2024.
- Cash from Financing Activities shows a five-year compound annual growth rate of -11.3% (FY2020 to FY2025).
- In earlier years, Cash from Financing Activities was $64.86 million in FY2024 (+210.6%), $20.88 million in FY2023 (-64.9%), $59.48 million in FY2022 (-50.7%) and $120.68 million in FY2021 (+281.8%).
- The Q2 2026 figure marks the highest quarterly Cash from Financing Activities since Q2 2021.
- The best year-over-year quarter for Cash from Financing Activities over five years was Q3 2022 (growth of 774.5%); the worst was Q4 2025 (a decline of 100.0%).
- Per Business Quant data, OCGN's Cash from Financing Activities in the three quarters before Q2 2026 was $34.98 million (Q1 2026), $2,000 (Q4 2025) and $18.51 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Ocugen | 349.22 Mn | 165.73 Mn | - | 80.37 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.37 Mn |
| Mar 31, 2026 | 34.98 Mn |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 18.51 Mn |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | -1.25 Mn |
| Dec 31, 2024 | 30.17 Mn |
| Sep 30, 2024 | 34.79 Mn |
| Jun 30, 2024 | 45,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | -35,000.00 |
| Jun 30, 2023 | 15.40 Mn |
| Mar 31, 2023 | 5.50 Mn |
| Dec 31, 2022 | 8.18 Mn |
| Sep 30, 2022 | 962,000.00 |
| Jun 30, 2022 | 236,000.00 |
| Mar 31, 2022 | 50.10 Mn |
| Dec 31, 2021 | 605,000.00 |
| Sep 30, 2021 | 110,000.00 |
Ocugen Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OCGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "OCGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OCGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();